NSC |
Compound |
Enrichment |
Correlation |
NSC 105014 |
Cladribine |
0.000931492155975116 |
0.37281054 |
NSC 163424 |
4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- |
0.000931492155975116 |
0.44561923 |
NSC 173552 |
L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate |
0.000931492155975116 |
0.6333488 |
NSC 115928 |
Benzonitrile, 3-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)-, monoethanesulfonate (9CI) |
0.00109467026514912 |
0.58643301 |
NSC 134228 |
.alpha.-Toluenethiol, .alpha.-(nitromethyl)-,acetate (ester) (8CI) |
0.00109467026514912 |
0.20426024 |
NSC 287459 |
Cytarabine AY |
0.00109467026514912 |
0.3718321 |
NSC 651777 |
Null |
0.00109467026514912 |
0.45431168 |
NSC 724037 |
Null |
0.00109467026514912 |
0.56391803 |
NSC 726671 |
Null |
0.00109467026514912 |
0.34425044 |
NSC 335766 |
Quinazoline, 4-ethyl-6-methoxy-7-(oxiranylmethoxy)- |
0.00119931827492062 |
0.37480353 |